Masimo

Masimo logo

Masimo Corporation is an American global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. Founded in 1989 by electrical engineer Joe Kiani, Masimo was created with the mission to improve patient outcomes and reduce the cost of care by taking noninvasive monitoring to new sites and applications. The company's headquarters are located in Irvine, California, United States.

History

Masimo was founded in 1989 by Joe Kiani, who has served as CEO and Chairman of the Board since the company's inception. The company initially focused on improving the pulse oximetry technology, which is used to measure the oxygen saturation level in a patient's blood. Masimo's breakthrough came with the invention of Signal Extraction Technology (SET), which significantly reduced false alarms and improved the accuracy of pulse oximetry readings, particularly in challenging conditions such as patient movement or low blood flow.

Products

Masimo's product line has expanded beyond pulse oximetry to include a variety of noninvasive monitoring technologies. Some of their key products include:

• Masimo SET® Pulse Oximetry: This is Masimo's flagship technology, which provides accurate measurements of blood oxygen saturation and pulse rates even in challenging conditions.
• Rainbow SET® Pulse CO-Oximetry: An advanced form of pulse oximetry that can measure multiple blood constituents and parameters beyond oxygen saturation, including carboxyhemoglobin, methemoglobin, and total hemoglobin.
• Root® Patient Monitoring and Connectivity Platform: A comprehensive monitoring platform that integrates a variety of monitoring technologies and devices on a single, customizable screen.
• Rad-97™ Pulse CO-Oximeter: A compact, standalone monitor that provides Masimo SET® pulse oximetry, Rainbow SET® Pulse CO-Oximetry, and other monitoring capabilities.

Innovations and Impact

Masimo is known for its commitment to innovation, having introduced several technologies that have made significant impacts on patient care. Their Signal Extraction Technology (SET) for pulse oximetry has been shown in multiple studies to reduce false alarms and increase the detection of true clinical events, leading to improved patient safety and reduced cost of care.

The company's development of Rainbow SET® Pulse CO-Oximetry has also been a significant advancement, allowing clinicians to noninvasively monitor multiple blood constituents that previously required invasive procedures to measure. This technology has applications in detecting conditions such as carbon monoxide poisoning and methemoglobinemia.

Corporate Social Responsibility

Masimo is committed to social responsibility, with initiatives focused on improving global health and access to innovative medical technologies. The company has been involved in various philanthropic activities, including donations of their technologies to underserved areas and disaster-stricken regions.

Controversies

Like many companies in the medical technology sector, Masimo has faced its share of controversies, including legal battles over patent infringements and disputes with other companies in the industry. However, Masimo has continued to focus on innovation and improving patient care through its technologies.

See Also

• Pulse Oximetry
• Medical Device
• Patient Monitoring

Masimo Resources
Latest articles Most recent articles Ongoing trials	Wikipedia